Home/Filings/4/0001638599-17-000342
4//SEC Filing

iBio, Inc. 4

Accession 0001638599-17-000342

$IBIOCIK 0001420720operating

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 4:01 PM ET

Size

7.5 KB

Accession

0001638599-17-000342

Insider Transaction Report

Form 4
Period: 2014-09-05
Chang Glenn
Director
Transactions
  • Award

    Stock Option (right to buy)

    2014-09-05$0.49/sh+60,000$29,400390,000 total
    Exercise: $0.49Exp: 2024-09-05Common Stock (60,000 underlying)
  • Award

    Stock Option (right to buy)

    2015-09-04$1.72/sh+100,000$172,000490,000 total
    Exercise: $1.72Exp: 2025-09-04Common Stock (100,000 underlying)
Footnotes (2)
  • [F1](1) Vesting starts 7/1/2014, in equal annual installments over three years.
  • [F2](2) Vesting starts 7/1/2015, in equal annual installments over year.

Issuer

iBio, Inc.

CIK 0001420720

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001420720

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:01 PM ET
Size
7.5 KB